Results 11 to 20 of about 63,231 (206)

Feasibility and outcome of CT-guided lung biopsy in patients with hematological diseases and suspected fungal pneumonia

open access: yesJournal of Infection in Developing Countries, 2013
Introduction: Fungal pneumonia is a major cause of morbidity and mortality in immunocompromised patients with hematological diseases. This study is aimed to evaluate the feasibility and outcome of computed tomography (CT) guided lung biopsy or fine ...
Sanjeev Kumar Sharma   +9 more
doaj   +1 more source

Pulmonary histoplasmoma: a disguised malady

open access: yesAutopsy and Case Reports, 2019
Histoplasmosis is a mycosis caused by the dimorphic fungus, Histoplasma capsulatum, which is transmitted via dust and aerosols. Lung involvement is the most common, with a varied clinical presentation.
Paulo Marcelo Pontes Gomes de Matos   +2 more
doaj   +1 more source

Saccharomyces cerevisiae expressing Gp43 protects mice against Paracoccidioides brasiliensis infection. [PDF]

open access: yesPLoS ONE, 2015
The dimorphic fungus Paracoccidioides brasiliensis is the etiological agent of paracoccidioidomycosis (PCM). It is believed that approximately 10 million people are infected with the fungus and approximately 2% will eventually develop the disease. Unlike
Mariana Aprigio Assis-Marques   +5 more
doaj   +1 more source

Clinical characteristics and risk factors of invasive fungal disease after hematopoietic stem cell transplantation: report of 233 cases

open access: yesDi-san junyi daxue xuebao, 2020
Objective To investigate the clinical characteristics of invasive fungal disease (IFD) after hematopoietic stem cell transplantation (HSCT) in the patients with hematological diseases, and analyze the risk factors of IFD after HSCT.
MA Lei   +5 more
doaj   +1 more source

Disseminated histoplasmosis in a patient with rheumatoid arthritis and interstitial lung disease

open access: yesApollo Medicine, 2022
Histoplasmosis is a rare systemic fungal ailment. The clinical presentation of this disease is nonspecific and most physicians lack awareness about this disease.
Deepak Rosha   +3 more
doaj   +1 more source

Application of Lung Diseases Detection based on CSLNet

open access: yesJurnal Nasional Pendidikan Teknik Informatika (JANAPATI), 2023
Lung diseases caused by fungal or bacterial infections can lead to inflammation in lung and even death when not detected early. A standard method for diagnosing lung diseases is the use of chest X-ray, which require careful examination of X-ray images ...
Panji Bintoro   +4 more
doaj   +1 more source

Pathogenic Fungal Infection in the Lung

open access: yesFrontiers in Immunology, 2019
Respiratory fungal infection is a severe clinical problem, especially in patients with compromised immune functions. Aspergillus, Cryptococcus, Pneumocystis, and endemic fungi are major pulmonary fungal pathogens that are able to result in life ...
Zhi Li, Zhi Li, Gen Lu, Guangxun Meng
doaj   +1 more source

Homobifunctional imidoester-modified zinc nano-spindle attenuated hyphae growth of Aspergillus against hypersensitivity responses

open access: yesiScience, 2023
Summary: Fungi cause various forms of invasive fungal disease (IFD), and fungal sensitization can contribute to the development of asthma, asthma severity, and other hypersensitivity diseases, such as atopic dermatitis (AD). In this study, we introduce a
Huifang Liu   +8 more
doaj   +1 more source

Disseminated Scedosporium apiospermum central nervous system infection after lung transplantation: A case report with successful recovery

open access: yesMedical Mycology Case Reports, 2019
Scedosporium species are fungal opportunistic pathogens frequently seen in chronic lung diseases such as in cystic fibrosis (CF). They can cause a wide spectrum of diseases mainly in immunodeficient patients.
Juuso Paajanen   +3 more
doaj   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Home - About - Disclaimer - Privacy